does nourish offer glp-1 & Thrive: A Dietitian’s Guide to Support for Women Over 40 Nutrition Support

Footnotes Disclosures: Dr

Regulatory re-positioning of obesity as a cardiometabolic disease, payer re-classification of GLP-1 receptor agonists as essential therapies after positive cardiovascular-outcome trials, and rapid employer adoption of coverage are converging to accelerate prescription volumes

GLP-1 adjudicated volume grew at an unprecedented rate after the release of Mounjaro, though it lagged the growth of written demand, meaning that as more GLP-1 prescriptions were written, a greater proportion of prescriptions were also rejected or abandoned

Theres no pressure

Best results are achieved alongside a healthy diet and consistent exercise

To fully realize the potential of GLP-1 receptor agonists, experts note that a multi-faceted approach is needed